nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—Methotrexate—ankylosing spondylitis	0.459	1	CrCtD
Raltitrexed—FPGS—Methotrexate—ankylosing spondylitis	0.165	0.739	CbGbCtD
Raltitrexed—Leucovorin—Methotrexate—ankylosing spondylitis	0.0607	0.2	CrCrCtD
Raltitrexed—Folic Acid—Methotrexate—ankylosing spondylitis	0.0607	0.2	CrCrCtD
Raltitrexed—Tetrahydrofolic acid—Methotrexate—ankylosing spondylitis	0.0607	0.2	CrCrCtD
Raltitrexed—Pemetrexed—Methotrexate—ankylosing spondylitis	0.0607	0.2	CrCrCtD
Raltitrexed—Pralatrexate—Methotrexate—ankylosing spondylitis	0.0607	0.2	CrCrCtD
Raltitrexed—TYMS—Methotrexate—ankylosing spondylitis	0.0584	0.261	CbGbCtD
Raltitrexed—Febrile neutropenia—Prednisone—ankylosing spondylitis	0.000223	0.0179	CcSEcCtD
Raltitrexed—Necrosis—Methylprednisolone—ankylosing spondylitis	0.000216	0.0173	CcSEcCtD
Raltitrexed—Necrosis—Dexamethasone—ankylosing spondylitis	0.000196	0.0158	CcSEcCtD
Raltitrexed—Necrosis—Betamethasone—ankylosing spondylitis	0.000196	0.0158	CcSEcCtD
Raltitrexed—Febrile neutropenia—Methotrexate—ankylosing spondylitis	0.000186	0.015	CcSEcCtD
Raltitrexed—Extravasation—Dexamethasone—ankylosing spondylitis	0.000177	0.0142	CcSEcCtD
Raltitrexed—Extravasation—Betamethasone—ankylosing spondylitis	0.000177	0.0142	CcSEcCtD
Raltitrexed—Necrosis—Prednisone—ankylosing spondylitis	0.000171	0.0137	CcSEcCtD
Raltitrexed—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.000162	0.013	CcSEcCtD
Raltitrexed—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.000162	0.013	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.000148	0.0119	CcSEcCtD
Raltitrexed—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.000147	0.0118	CcSEcCtD
Raltitrexed—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.000147	0.0118	CcSEcCtD
Raltitrexed—Necrosis—Methotrexate—ankylosing spondylitis	0.000143	0.0115	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.000136	0.0109	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.000136	0.0109	CcSEcCtD
Raltitrexed—Extravasation—Methotrexate—ankylosing spondylitis	0.000128	0.0103	CcSEcCtD
Raltitrexed—Skin exfoliation—Prednisone—ankylosing spondylitis	0.000128	0.0103	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.000123	0.0099	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.000123	0.0099	CcSEcCtD
Raltitrexed—Sepsis—Prednisone—ankylosing spondylitis	0.000116	0.00935	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.000107	0.00862	CcSEcCtD
Raltitrexed—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.000107	0.0086	CcSEcCtD
Raltitrexed—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.000101	0.00814	CcSEcCtD
Raltitrexed—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.0001	0.00806	CcSEcCtD
Raltitrexed—Sepsis—Methotrexate—ankylosing spondylitis	9.73e-05	0.00781	CcSEcCtD
Raltitrexed—Conjunctivitis—Triamcinolone—ankylosing spondylitis	9.23e-05	0.00741	CcSEcCtD
Raltitrexed—Sweating—Methylprednisolone—ankylosing spondylitis	9.08e-05	0.0073	CcSEcCtD
Raltitrexed—Hepatic failure—Methotrexate—ankylosing spondylitis	9.06e-05	0.00727	CcSEcCtD
Raltitrexed—Weight decreased—Dexamethasone—ankylosing spondylitis	8.74e-05	0.00702	CcSEcCtD
Raltitrexed—Weight decreased—Betamethasone—ankylosing spondylitis	8.74e-05	0.00702	CcSEcCtD
Raltitrexed—Conjunctivitis—Betamethasone—ankylosing spondylitis	8.38e-05	0.00673	CcSEcCtD
Raltitrexed—Conjunctivitis—Dexamethasone—ankylosing spondylitis	8.38e-05	0.00673	CcSEcCtD
Raltitrexed—Arrhythmia—Prednisolone—ankylosing spondylitis	8.28e-05	0.00665	CcSEcCtD
Raltitrexed—Neutropenia—Prednisone—ankylosing spondylitis	7.87e-05	0.00632	CcSEcCtD
Raltitrexed—Arrhythmia—Triamcinolone—ankylosing spondylitis	7.62e-05	0.00612	CcSEcCtD
Raltitrexed—Weight decreased—Prednisone—ankylosing spondylitis	7.61e-05	0.00612	CcSEcCtD
Raltitrexed—Arrhythmia—Methylprednisolone—ankylosing spondylitis	7.6e-05	0.0061	CcSEcCtD
Raltitrexed—Ill-defined disorder—Prednisolone—ankylosing spondylitis	7.49e-05	0.00601	CcSEcCtD
Raltitrexed—Malaise—Prednisolone—ankylosing spondylitis	7.28e-05	0.00584	CcSEcCtD
Raltitrexed—Dysgeusia—Triamcinolone—ankylosing spondylitis	7.27e-05	0.00584	CcSEcCtD
Raltitrexed—Arrhythmia—Dexamethasone—ankylosing spondylitis	6.91e-05	0.00555	CcSEcCtD
Raltitrexed—Arrhythmia—Betamethasone—ankylosing spondylitis	6.91e-05	0.00555	CcSEcCtD
Raltitrexed—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	6.89e-05	0.00553	CcSEcCtD
Raltitrexed—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	6.87e-05	0.00552	CcSEcCtD
Raltitrexed—Alopecia—Dexamethasone—ankylosing spondylitis	6.84e-05	0.00549	CcSEcCtD
Raltitrexed—Alopecia—Betamethasone—ankylosing spondylitis	6.84e-05	0.00549	CcSEcCtD
Raltitrexed—Discomfort—Prednisolone—ankylosing spondylitis	6.79e-05	0.00545	CcSEcCtD
Raltitrexed—Malaise—Triamcinolone—ankylosing spondylitis	6.69e-05	0.00537	CcSEcCtD
Raltitrexed—Malaise—Methylprednisolone—ankylosing spondylitis	6.68e-05	0.00536	CcSEcCtD
Raltitrexed—Oedema—Prednisolone—ankylosing spondylitis	6.59e-05	0.00529	CcSEcCtD
Raltitrexed—Neutropenia—Methotrexate—ankylosing spondylitis	6.58e-05	0.00528	CcSEcCtD
Raltitrexed—Cough—Triamcinolone—ankylosing spondylitis	6.48e-05	0.0052	CcSEcCtD
Raltitrexed—Hyperhidrosis—Prednisolone—ankylosing spondylitis	6.37e-05	0.00511	CcSEcCtD
Raltitrexed—Arthralgia—Methylprednisolone—ankylosing spondylitis	6.3e-05	0.00506	CcSEcCtD
Raltitrexed—Ill-defined disorder—Betamethasone—ankylosing spondylitis	6.25e-05	0.00502	CcSEcCtD
Raltitrexed—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	6.25e-05	0.00502	CcSEcCtD
Raltitrexed—Discomfort—Triamcinolone—ankylosing spondylitis	6.24e-05	0.00501	CcSEcCtD
Raltitrexed—Discomfort—Methylprednisolone—ankylosing spondylitis	6.23e-05	0.005	CcSEcCtD
Raltitrexed—Renal failure—Methotrexate—ankylosing spondylitis	6.16e-05	0.00495	CcSEcCtD
Raltitrexed—Stomatitis—Methotrexate—ankylosing spondylitis	6.11e-05	0.00491	CcSEcCtD
Raltitrexed—Conjunctivitis—Methotrexate—ankylosing spondylitis	6.1e-05	0.0049	CcSEcCtD
Raltitrexed—Malaise—Betamethasone—ankylosing spondylitis	6.07e-05	0.00488	CcSEcCtD
Raltitrexed—Malaise—Dexamethasone—ankylosing spondylitis	6.07e-05	0.00488	CcSEcCtD
Raltitrexed—Oedema—Triamcinolone—ankylosing spondylitis	6.06e-05	0.00486	CcSEcCtD
Raltitrexed—Arrhythmia—Prednisone—ankylosing spondylitis	6.02e-05	0.00483	CcSEcCtD
Raltitrexed—Infection—Triamcinolone—ankylosing spondylitis	6.02e-05	0.00483	CcSEcCtD
Raltitrexed—Sweating—Methotrexate—ankylosing spondylitis	6.01e-05	0.00483	CcSEcCtD
Raltitrexed—Infection—Methylprednisolone—ankylosing spondylitis	6e-05	0.00482	CcSEcCtD
Raltitrexed—Alopecia—Prednisone—ankylosing spondylitis	5.95e-05	0.00478	CcSEcCtD
Raltitrexed—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	5.86e-05	0.0047	CcSEcCtD
Raltitrexed—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	5.84e-05	0.00469	CcSEcCtD
Raltitrexed—TYMS—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	5.73e-05	0.0331	CbGdCrCtD
Raltitrexed—Discomfort—Betamethasone—ankylosing spondylitis	5.66e-05	0.00455	CcSEcCtD
Raltitrexed—Discomfort—Dexamethasone—ankylosing spondylitis	5.66e-05	0.00455	CcSEcCtD
Raltitrexed—TYMS—Flunisolide—Methylprednisolone—ankylosing spondylitis	5.66e-05	0.0327	CbGdCrCtD
Raltitrexed—TYMS—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	5.64e-05	0.0326	CbGdCrCtD
Raltitrexed—TYMS—Clobetasol propionate—Betamethasone—ankylosing spondylitis	5.64e-05	0.0326	CbGdCrCtD
Raltitrexed—Pain—Prednisolone—ankylosing spondylitis	5.63e-05	0.00452	CcSEcCtD
Raltitrexed—TYMS—Triamcinolone—Methylprednisolone—ankylosing spondylitis	5.6e-05	0.0324	CbGdCrCtD
Raltitrexed—TYMS—Flunisolide—Dexamethasone—ankylosing spondylitis	5.57e-05	0.0322	CbGdCrCtD
Raltitrexed—TYMS—Flunisolide—Betamethasone—ankylosing spondylitis	5.57e-05	0.0322	CbGdCrCtD
Raltitrexed—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	5.52e-05	0.00443	CcSEcCtD
Raltitrexed—TYMS—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	5.51e-05	0.0319	CbGdCrCtD
Raltitrexed—TYMS—Triamcinolone—Betamethasone—ankylosing spondylitis	5.51e-05	0.0319	CbGdCrCtD
Raltitrexed—TYMS—Triamcinolone—Dexamethasone—ankylosing spondylitis	5.51e-05	0.0319	CbGdCrCtD
Raltitrexed—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	5.51e-05	0.00442	CcSEcCtD
Raltitrexed—Oedema—Dexamethasone—ankylosing spondylitis	5.5e-05	0.00441	CcSEcCtD
Raltitrexed—Oedema—Betamethasone—ankylosing spondylitis	5.5e-05	0.00441	CcSEcCtD
Raltitrexed—Infection—Dexamethasone—ankylosing spondylitis	5.46e-05	0.00438	CcSEcCtD
Raltitrexed—Infection—Betamethasone—ankylosing spondylitis	5.46e-05	0.00438	CcSEcCtD
Raltitrexed—TYMS—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	5.46e-05	0.0316	CbGdCrCtD
Raltitrexed—Ill-defined disorder—Prednisone—ankylosing spondylitis	5.44e-05	0.00437	CcSEcCtD
Raltitrexed—TYMS—Flunisolide—Triamcinolone—ankylosing spondylitis	5.44e-05	0.0315	CbGdCrCtD
Raltitrexed—Feeling abnormal—Prednisolone—ankylosing spondylitis	5.43e-05	0.00436	CcSEcCtD
Raltitrexed—Anaemia—Prednisone—ankylosing spondylitis	5.42e-05	0.00435	CcSEcCtD
Raltitrexed—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	5.38e-05	0.00432	CcSEcCtD
Raltitrexed—Thrombocytopenia—Betamethasone—ankylosing spondylitis	5.38e-05	0.00432	CcSEcCtD
Raltitrexed—TYMS—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	5.37e-05	0.0311	CbGdCrCtD
Raltitrexed—TYMS—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	5.37e-05	0.0311	CbGdCrCtD
Raltitrexed—Dyspepsia—Triamcinolone—ankylosing spondylitis	5.33e-05	0.00428	CcSEcCtD
Raltitrexed—Dyspepsia—Methylprednisolone—ankylosing spondylitis	5.32e-05	0.00427	CcSEcCtD
Raltitrexed—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	5.31e-05	0.00427	CcSEcCtD
Raltitrexed—Hyperhidrosis—Betamethasone—ankylosing spondylitis	5.31e-05	0.00427	CcSEcCtD
Raltitrexed—Malaise—Prednisone—ankylosing spondylitis	5.29e-05	0.00425	CcSEcCtD
Raltitrexed—TYMS—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	5.25e-05	0.0304	CbGdCrCtD
Raltitrexed—Anorexia—Betamethasone—ankylosing spondylitis	5.24e-05	0.00421	CcSEcCtD
Raltitrexed—Anorexia—Dexamethasone—ankylosing spondylitis	5.24e-05	0.00421	CcSEcCtD
Raltitrexed—TYMS—Clobetasol propionate—Prednisone—ankylosing spondylitis	5.23e-05	0.0302	CbGdCrCtD
Raltitrexed—Pain—Triamcinolone—ankylosing spondylitis	5.18e-05	0.00416	CcSEcCtD
Raltitrexed—TYMS—Flunisolide—Prednisone—ankylosing spondylitis	5.16e-05	0.0299	CbGdCrCtD
Raltitrexed—TYMS—Diflorasone—Methylprednisolone—ankylosing spondylitis	5.16e-05	0.0298	CbGdCrCtD
Raltitrexed—TYMS—Triamcinolone—Prednisone—ankylosing spondylitis	5.11e-05	0.0295	CbGdCrCtD
Raltitrexed—TYMS—Clobetasol propionate—Prednisolone—ankylosing spondylitis	5.1e-05	0.0295	CbGdCrCtD
Raltitrexed—TYMS—Diflorasone—Dexamethasone—ankylosing spondylitis	5.08e-05	0.0294	CbGdCrCtD
Raltitrexed—TYMS—Diflorasone—Betamethasone—ankylosing spondylitis	5.08e-05	0.0294	CbGdCrCtD
Raltitrexed—TYMS—Flunisolide—Prednisolone—ankylosing spondylitis	5.04e-05	0.0291	CbGdCrCtD
Raltitrexed—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	5.01e-05	0.00402	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	5.01e-05	0.00402	CcSEcCtD
Raltitrexed—Arthralgia—Prednisone—ankylosing spondylitis	4.99e-05	0.00401	CcSEcCtD
Raltitrexed—Feeling abnormal—Triamcinolone—ankylosing spondylitis	4.99e-05	0.00401	CcSEcCtD
Raltitrexed—TYMS—Triamcinolone—Prednisolone—ankylosing spondylitis	4.99e-05	0.0288	CbGdCrCtD
Raltitrexed—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	4.98e-05	0.004	CcSEcCtD
Raltitrexed—Alopecia—Methotrexate—ankylosing spondylitis	4.98e-05	0.004	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Triamcinolone—ankylosing spondylitis	4.96e-05	0.0287	CbGdCrCtD
Raltitrexed—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	4.94e-05	0.00397	CcSEcCtD
Raltitrexed—Discomfort—Prednisone—ankylosing spondylitis	4.93e-05	0.00396	CcSEcCtD
Raltitrexed—Dyspepsia—Betamethasone—ankylosing spondylitis	4.84e-05	0.00389	CcSEcCtD
Raltitrexed—Dyspepsia—Dexamethasone—ankylosing spondylitis	4.84e-05	0.00389	CcSEcCtD
Raltitrexed—Dysgeusia—Methotrexate—ankylosing spondylitis	4.8e-05	0.00385	CcSEcCtD
Raltitrexed—Body temperature increased—Triamcinolone—ankylosing spondylitis	4.79e-05	0.00385	CcSEcCtD
Raltitrexed—Oedema—Prednisone—ankylosing spondylitis	4.79e-05	0.00384	CcSEcCtD
Raltitrexed—Abdominal pain—Methylprednisolone—ankylosing spondylitis	4.78e-05	0.00384	CcSEcCtD
Raltitrexed—Decreased appetite—Betamethasone—ankylosing spondylitis	4.78e-05	0.00384	CcSEcCtD
Raltitrexed—Decreased appetite—Dexamethasone—ankylosing spondylitis	4.78e-05	0.00384	CcSEcCtD
Raltitrexed—Infection—Prednisone—ankylosing spondylitis	4.75e-05	0.00382	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Prednisone—ankylosing spondylitis	4.71e-05	0.0272	CbGdCrCtD
Raltitrexed—Pain—Betamethasone—ankylosing spondylitis	4.7e-05	0.00377	CcSEcCtD
Raltitrexed—Pain—Dexamethasone—ankylosing spondylitis	4.7e-05	0.00377	CcSEcCtD
Raltitrexed—Hyperhidrosis—Prednisone—ankylosing spondylitis	4.63e-05	0.00372	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Prednisolone—ankylosing spondylitis	4.6e-05	0.0266	CbGdCrCtD
Raltitrexed—Anorexia—Prednisone—ankylosing spondylitis	4.56e-05	0.00366	CcSEcCtD
Raltitrexed—Ill-defined disorder—Methotrexate—ankylosing spondylitis	4.55e-05	0.00365	CcSEcCtD
Raltitrexed—Anaemia—Methotrexate—ankylosing spondylitis	4.53e-05	0.00364	CcSEcCtD
Raltitrexed—Feeling abnormal—Dexamethasone—ankylosing spondylitis	4.53e-05	0.00364	CcSEcCtD
Raltitrexed—Feeling abnormal—Betamethasone—ankylosing spondylitis	4.53e-05	0.00364	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Methylprednisolone—ankylosing spondylitis	4.52e-05	0.0262	CbGdCrCtD
Raltitrexed—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	4.49e-05	0.00361	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	4.49e-05	0.00361	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Dexamethasone—ankylosing spondylitis	4.45e-05	0.0257	CbGdCrCtD
Raltitrexed—TYMS—Budesonide—Betamethasone—ankylosing spondylitis	4.45e-05	0.0257	CbGdCrCtD
Raltitrexed—Malaise—Methotrexate—ankylosing spondylitis	4.42e-05	0.00355	CcSEcCtD
Raltitrexed—Leukopenia—Methotrexate—ankylosing spondylitis	4.39e-05	0.00352	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	4.36e-05	0.0035	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Triamcinolone—ankylosing spondylitis	4.35e-05	0.0252	CbGdCrCtD
Raltitrexed—Asthenia—Triamcinolone—ankylosing spondylitis	4.35e-05	0.00349	CcSEcCtD
Raltitrexed—Abdominal pain—Dexamethasone—ankylosing spondylitis	4.34e-05	0.00349	CcSEcCtD
Raltitrexed—Abdominal pain—Betamethasone—ankylosing spondylitis	4.34e-05	0.00349	CcSEcCtD
Raltitrexed—Body temperature increased—Betamethasone—ankylosing spondylitis	4.34e-05	0.00349	CcSEcCtD
Raltitrexed—Body temperature increased—Dexamethasone—ankylosing spondylitis	4.34e-05	0.00349	CcSEcCtD
Raltitrexed—Asthenia—Methylprednisolone—ankylosing spondylitis	4.34e-05	0.00348	CcSEcCtD
Raltitrexed—Pruritus—Triamcinolone—ankylosing spondylitis	4.29e-05	0.00344	CcSEcCtD
Raltitrexed—Cough—Methotrexate—ankylosing spondylitis	4.28e-05	0.00343	CcSEcCtD
Raltitrexed—Pruritus—Methylprednisolone—ankylosing spondylitis	4.28e-05	0.00343	CcSEcCtD
Raltitrexed—Dyspepsia—Prednisone—ankylosing spondylitis	4.21e-05	0.00338	CcSEcCtD
Raltitrexed—Arthralgia—Methotrexate—ankylosing spondylitis	4.17e-05	0.00335	CcSEcCtD
Raltitrexed—Decreased appetite—Prednisone—ankylosing spondylitis	4.16e-05	0.00334	CcSEcCtD
Raltitrexed—Rash—Prednisolone—ankylosing spondylitis	4.15e-05	0.00334	CcSEcCtD
Raltitrexed—Dermatitis—Prednisolone—ankylosing spondylitis	4.15e-05	0.00333	CcSEcCtD
Raltitrexed—Diarrhoea—Methylprednisolone—ankylosing spondylitis	4.13e-05	0.00332	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Prednisone—ankylosing spondylitis	4.13e-05	0.0239	CbGdCrCtD
Raltitrexed—Headache—Prednisolone—ankylosing spondylitis	4.13e-05	0.00331	CcSEcCtD
Raltitrexed—Discomfort—Methotrexate—ankylosing spondylitis	4.12e-05	0.00331	CcSEcCtD
Raltitrexed—Constipation—Prednisone—ankylosing spondylitis	4.09e-05	0.00329	CcSEcCtD
Raltitrexed—TYMS—Budesonide—Prednisolone—ankylosing spondylitis	4.03e-05	0.0233	CbGdCrCtD
Raltitrexed—Infection—Methotrexate—ankylosing spondylitis	3.97e-05	0.00319	CcSEcCtD
Raltitrexed—TYMS—Danazol—Prednisone—ankylosing spondylitis	3.96e-05	0.0229	CbGdCrCtD
Raltitrexed—Feeling abnormal—Prednisone—ankylosing spondylitis	3.94e-05	0.00317	CcSEcCtD
Raltitrexed—Asthenia—Dexamethasone—ankylosing spondylitis	3.94e-05	0.00317	CcSEcCtD
Raltitrexed—Asthenia—Betamethasone—ankylosing spondylitis	3.94e-05	0.00317	CcSEcCtD
Raltitrexed—Thrombocytopenia—Methotrexate—ankylosing spondylitis	3.92e-05	0.00315	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Prednisone—ankylosing spondylitis	3.91e-05	0.00314	CcSEcCtD
Raltitrexed—Nausea—Prednisolone—ankylosing spondylitis	3.91e-05	0.00314	CcSEcCtD
Raltitrexed—Pruritus—Dexamethasone—ankylosing spondylitis	3.89e-05	0.00312	CcSEcCtD
Raltitrexed—Pruritus—Betamethasone—ankylosing spondylitis	3.89e-05	0.00312	CcSEcCtD
Raltitrexed—Hyperhidrosis—Methotrexate—ankylosing spondylitis	3.87e-05	0.00311	CcSEcCtD
Raltitrexed—Vomiting—Triamcinolone—ankylosing spondylitis	3.85e-05	0.00309	CcSEcCtD
Raltitrexed—Vomiting—Methylprednisolone—ankylosing spondylitis	3.84e-05	0.00309	CcSEcCtD
Raltitrexed—Rash—Triamcinolone—ankylosing spondylitis	3.82e-05	0.00307	CcSEcCtD
Raltitrexed—Dermatitis—Triamcinolone—ankylosing spondylitis	3.82e-05	0.00306	CcSEcCtD
Raltitrexed—Anorexia—Methotrexate—ankylosing spondylitis	3.81e-05	0.00306	CcSEcCtD
Raltitrexed—Rash—Methylprednisolone—ankylosing spondylitis	3.81e-05	0.00306	CcSEcCtD
Raltitrexed—Dermatitis—Methylprednisolone—ankylosing spondylitis	3.81e-05	0.00306	CcSEcCtD
Raltitrexed—Headache—Triamcinolone—ankylosing spondylitis	3.79e-05	0.00305	CcSEcCtD
Raltitrexed—Headache—Methylprednisolone—ankylosing spondylitis	3.79e-05	0.00304	CcSEcCtD
Raltitrexed—Abdominal pain—Prednisone—ankylosing spondylitis	3.78e-05	0.00304	CcSEcCtD
Raltitrexed—Body temperature increased—Prednisone—ankylosing spondylitis	3.78e-05	0.00304	CcSEcCtD
Raltitrexed—Diarrhoea—Betamethasone—ankylosing spondylitis	3.76e-05	0.00302	CcSEcCtD
Raltitrexed—Diarrhoea—Dexamethasone—ankylosing spondylitis	3.76e-05	0.00302	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	3.64e-05	0.00293	CcSEcCtD
Raltitrexed—Nausea—Triamcinolone—ankylosing spondylitis	3.6e-05	0.00289	CcSEcCtD
Raltitrexed—Nausea—Methylprednisolone—ankylosing spondylitis	3.59e-05	0.00288	CcSEcCtD
Raltitrexed—Dyspepsia—Methotrexate—ankylosing spondylitis	3.52e-05	0.00283	CcSEcCtD
Raltitrexed—Vomiting—Dexamethasone—ankylosing spondylitis	3.49e-05	0.00281	CcSEcCtD
Raltitrexed—Vomiting—Betamethasone—ankylosing spondylitis	3.49e-05	0.00281	CcSEcCtD
Raltitrexed—Decreased appetite—Methotrexate—ankylosing spondylitis	3.48e-05	0.00279	CcSEcCtD
Raltitrexed—Rash—Betamethasone—ankylosing spondylitis	3.47e-05	0.00278	CcSEcCtD
Raltitrexed—Rash—Dexamethasone—ankylosing spondylitis	3.47e-05	0.00278	CcSEcCtD
Raltitrexed—Dermatitis—Dexamethasone—ankylosing spondylitis	3.46e-05	0.00278	CcSEcCtD
Raltitrexed—Dermatitis—Betamethasone—ankylosing spondylitis	3.46e-05	0.00278	CcSEcCtD
Raltitrexed—Headache—Betamethasone—ankylosing spondylitis	3.44e-05	0.00277	CcSEcCtD
Raltitrexed—Headache—Dexamethasone—ankylosing spondylitis	3.44e-05	0.00277	CcSEcCtD
Raltitrexed—Asthenia—Prednisone—ankylosing spondylitis	3.43e-05	0.00276	CcSEcCtD
Raltitrexed—Pain—Methotrexate—ankylosing spondylitis	3.42e-05	0.00275	CcSEcCtD
Raltitrexed—Pruritus—Prednisone—ankylosing spondylitis	3.39e-05	0.00272	CcSEcCtD
Raltitrexed—Feeling abnormal—Methotrexate—ankylosing spondylitis	3.3e-05	0.00265	CcSEcCtD
Raltitrexed—Diarrhoea—Prednisone—ankylosing spondylitis	3.27e-05	0.00263	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	3.27e-05	0.00263	CcSEcCtD
Raltitrexed—Nausea—Dexamethasone—ankylosing spondylitis	3.26e-05	0.00262	CcSEcCtD
Raltitrexed—Nausea—Betamethasone—ankylosing spondylitis	3.26e-05	0.00262	CcSEcCtD
Raltitrexed—Abdominal pain—Methotrexate—ankylosing spondylitis	3.16e-05	0.00254	CcSEcCtD
Raltitrexed—Body temperature increased—Methotrexate—ankylosing spondylitis	3.16e-05	0.00254	CcSEcCtD
Raltitrexed—Vomiting—Prednisone—ankylosing spondylitis	3.04e-05	0.00244	CcSEcCtD
Raltitrexed—Rash—Prednisone—ankylosing spondylitis	3.02e-05	0.00242	CcSEcCtD
Raltitrexed—Dermatitis—Prednisone—ankylosing spondylitis	3.01e-05	0.00242	CcSEcCtD
Raltitrexed—Headache—Prednisone—ankylosing spondylitis	3e-05	0.00241	CcSEcCtD
Raltitrexed—Asthenia—Methotrexate—ankylosing spondylitis	2.87e-05	0.0023	CcSEcCtD
Raltitrexed—Nausea—Prednisone—ankylosing spondylitis	2.84e-05	0.00228	CcSEcCtD
Raltitrexed—Pruritus—Methotrexate—ankylosing spondylitis	2.83e-05	0.00227	CcSEcCtD
Raltitrexed—Diarrhoea—Methotrexate—ankylosing spondylitis	2.74e-05	0.0022	CcSEcCtD
Raltitrexed—Vomiting—Methotrexate—ankylosing spondylitis	2.54e-05	0.00204	CcSEcCtD
Raltitrexed—Rash—Methotrexate—ankylosing spondylitis	2.52e-05	0.00203	CcSEcCtD
Raltitrexed—Dermatitis—Methotrexate—ankylosing spondylitis	2.52e-05	0.00202	CcSEcCtD
Raltitrexed—Headache—Methotrexate—ankylosing spondylitis	2.51e-05	0.00201	CcSEcCtD
Raltitrexed—Nausea—Methotrexate—ankylosing spondylitis	2.38e-05	0.00191	CcSEcCtD
